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Abstract
Stem-cell antigen 1–positive (Sca-1+) cardiac stem cells (CSCs), a vital kind of CSCs in humans, promote cardiac repair in vivo and can differentiate to cardiomyocytes with 50 -azacytizine treatment in vitro. However, the underlying molecular mechanisms are unknown. b-arrestin2 is an
important scaffold protein and highly expressed in the heart. To explore the function of b-arrestin2 in Sca-1+ CSC differentiation, we used b-arrestin2–knockout mice and overexpression strategies. Real-time PCR revealed that b-arrestin2 promoted 50 -azacytizine-induced Sca-1+ CSC
differentiation in vitro. Because the microRNA 155 (miR-155) may regulate b-arrestin2 expression, we detected its role and relationship with
b-arrestin2 and glycogen synthase kinase 3 (GSK3b), another probable target of miR-155. Real-time PCR revealed that miR-155, inhibited by
b-arrestin2, impaired 50 -azacytizine-induced Sca-1+ CSC differentiation. On luciferase report assay, miR-155 could inhibit the activity of b-arrestin2 and GSK3b, which suggests a loop pathway between miR-155 and b-arrestin2. Furthermore, b-arrestin2-knockout inhibited the activity
of GSK3b. Akt, the upstream inhibitor of GSK3b, was inhibited in b-arrestin2-Knockout mice, so the activity of GSK3b was regulated by b-arrestin2 not Akt. We transplanted Sca-1+ CSCs from b-arrestin2-knockout mice to mice with myocardial infarction and found similar protective
functions as in wild-type mice but impaired arterial elastance. Furthermore, low level of b-arrestin2 agreed with decreased phosphorylation of
AKT and increased phophorylation of GSK3b, similar to in vitro findings. The b-arrestin2/miR-155/GSK3b pathway may be a new mechanism
with implications for treatment of heart disease.
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Introduction
Acute myocardial infarction, characterized by the irreversible necrosis
of cardiac cells, causes a significant number of deaths every year.
The clinical trials of stem cells transplantation have not been consis-
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tent because these cells either do not differentiate into cardiac cells or
differentiate into only limited number of cardiac cells. More recently,
direct differentiation of resident cardiac stem cells (CSCs) into cardiomyocytes has given new hope for myocardial regeneration [1–3].
However, the mechanisms of CSCs differentiation into cardiomyocytes are little known.
Several kinds of resident CSCs, including stem-cell antigen
1–positive (Sca-1+), c-kit+ and side-population cells, have been identified in adult hearts [2, 4]. Transplantation of Sca-1+ into the
infarcted area of hearts promotes cardiac repair [5, 6], which indicates a key role of Sca-1+ resident CSCs in CSC differentiation and
therapy. Recently, Sca-1+ cells were found to different into
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cardiomyocytes after treatment with 5-azacytidine (5aza) in vitro [7,
8], this model helps in exploring the underlying mechanisms of Sca1+ cell differentiation into cardiomyocytes.
b-arrestins, abundantly expressed in cardiac muscle, are wellknown negative regulators of G-protein-coupled receptor signalling
and function as scaffold proteins to modulate G-protein-independent
signal cascades. b-arrestins consist of two proteins: b-arrestin1 and
b-arrestin2 (Arrb2). The expression of Arrb2 is induced in the failing
heart [9], and recent studies point to the beneficial role Arrb2 plays in
the heart [10]. However, the direct function and the mechanism of
Arrb2 mediated Sca-1+ CSC differentiation is not known yet.
MicroRNAs (miRNAs) are small 20- to 24-nt non-coding RNAs
found in diverse organisms. They have a broad impact on gene
expression via translational repression or post-transcriptional
suppression [11]. TargetScan analysis showed that many miRNAs
might regulate Arrb2. MiR-155 is a probable miRNA regulating Arrb2.
Furthermore, miR-155 was greatly downregulated in a myocardial
infarction model [12, 13], so miR-155 might have a protective function in cardiac injury. However, whether miR-155 participates in
Arrb2–regulated Sca-1+ cell differentiation is not clear.
In this study, we explored the mechanism of Arrb2 mediated
Sca-1+ CSC differentiation, and found b-arrestin2/miR-155/GSK3b
pathway regulates transition of 50 -azacytizine-induced Sca-1+ cells to
cardiomyocytes, which might be a new target for the treatment of
heart disease.

Materials and methods
Reagents
5aza and PKH2 green fluorescent cell linker kit were obtained from
Sigma-Aldrich (St. Louis, MO, USA). Lipofectamine 2000, and SYBR
GreenER were from Invitrogen (Grand Island, NY, USA). The MMLV
reverse transcription system and dual luciferase reporter assay system
were from Promega (Madison, MI, USA). TaqMan MicroRNA Assay,
TaqMan MicroRNA Reverse Transcription kit, and TaqMan Universal
PCR Master Mix were from Applied Biosystems (Foster, CA, USA). Antibodies, including total and phospho-GSK-3b (Ser 9), total and phosphoAkt (Ser 473), were from Cell Signaling Technology (Beverly, MA, USA).
Biotinylated Sca-1 antibody was from BD Biosciences (San Jose, CA,
USA). Antibodies for GAPDH and Arrb2 were from Santa Cruz Biotechnology (Santa Cruz, CA, USA). The cardiac troponin T (cTnT) antibody
was from Abcam (Cambridge, UK). GSK-3b inhibitor SB216763 was
from Tocris Bioscience (Bristol, UK).

Animals
10–12 weeks Arrb2-KO mice on a C57BL/6 background were provided
by Dr. Robert J. Lefkowitz (Duke University Medical Center, Durham,
NC). Wild-type (WT) C57BL/6 male mice were obtained from the Jackson Laboratory (Bar Harbor, ME, USA). All mice were maintained in the
Division of Laboratory Animal Resources at East Tennessee State University (ETSU), a facility accredited by the Association for the Assessment and Accreditation of Laboratory Animal Care International. Animal

care and experimental protocols were approved by the ETSU Committee
on Animal Care.

Cells culture
Cardiac Sca-1+ cells were isolated by magnetic cell sorting from C57Bl/
6 or Arrb2 knockout mice (10- to 12-week-old, C57Bl/6 background)
with about 98% purity, as described previously [14]. Briefly, hearts
from adult mice were treated with 0.1% collagenase for 30 min. followed by filtering through 80 lm mesh. To separate Sca-1+ cells, cells
were incubated with biotinylated anti-Sca-1 antibody (BD Biosciences)
for 15 min. on ice and washed with IMag buffer (consisting of PBS with
0.5% bovine serum albumin and 2 mM EDTA) followed by incubation
with streptavidin-conjugated particles for 30 min. on ice. Newly isolated
cardiac Sca-1+ were cultured on 1% gelatin-coated dishes with Iscove’s
modified Dulbecco’s medium supplemented with 10% foetal bovine
serum (FBS), 100 lg/ml penicillin, and 250 lg/ml streptomycin at 37°C
in humid air with 5% CO2. The separated Sca-1+ CSCs were lack of the
hematopoietic stem cell markers CD45 and CD34 (also a marker of
endothelial progenitor cells) and hematopoietic transcription factors
Lmo2, Gata2 and Tal [2]. At 1 day after seeding, cells were treated with
10 lM 5aza for the first 3 days; the medium was changed every
3 days. The dose and time of treatment with 5aza was reported previously [7, 8]. Human HEK293T cells were purchased from American
Type Culture Collection (USA).

Cell transfection and plasmids
Sca-1+ cells (3.5 9 105) in 350 ll gene pulse electroporation buffer
with 40 lg/ml DNA were transferred into a 0.4-cm cuvette. After a
pulse at 200 V, 250 lF, 1000 Ω, 10˝ with Bio-Rad MXcell (Bio-Rad,
Hercules, CA, USA), cells were transferred to 1% gelatin-coated wells of
a 24-well tissue culture plate containing 500 ll growth medium. Cells
were incubated with Iscove’s modified Dulbecco’s medium supplemented with 10% FBS and 10 lM 5aza for the first 3 days, then normal
culture medium. Arrb2 full-length and control vectors were generous
gifts from Dr. Gang Pei (Shanghai Institutes for Biological Sciences).

Real-time PCR (RT-PCR)
Total RNA was extracted and reverse-transcribed into cDNA. Quantified
RT-PCR was involved use of SYBR GreenER on the Bio-Rad PCR instrument. PCR reaction conditions were according to the standard protocol.
GAPDH was used as an endogenous control. All real-time PCR reactions
were performed in triplicate, and relative quantification involved the
DDCt method (95% CI). All primer sets were subjected to a dissociation
curve analysis and produced single peaks on a derivative plot of raw
fluorescence. Primer sequences for MYH6, GATA4, cTnT and b-actin
were as described [15].

Western blot analysis
Total proteins were extracted by use of RIPA lysis buffer (Pierce
Biotechnology, Rockford, IL, USA). Samples containing equal amounts
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of protein were separated by 8% SDS-PAGE and transferred onto
Hybond ECL membranes (Amersham Pharmacia, Piscataway, NJ, USA),
which were incubated overnight at 4°C with the appropriate primary
antibodies (1:1000), then incubated 1 hr at RT with peroxidase-conjugated secondary antibodies (1:5000). Blots were exposed to the SuperSignal West Dura Extended Duration substrate (Pierce). Signals were
quantified by scanning densitometry with the Bio-Image Analysis System (Bio-Rad).

Luciferase reporter assay
HEK293T cells were seeded on 96-well plates the day before transfection in antibiotic-free medium. Cells were cotransfected with 60 ng
miR-155 plasmid or control plasmid and 100 ng psicheck2 30 -UTR-WT
(WT Arrb2 or GSK3b 30 -UTR) or psicheck2 30 -UTR-MUT (mutant miR155 target site in Arrb2 or GSK3b 30 -UTR) by use of Lipofectamine
2000 (Invitrogen). After 48 hrs, cells were collected for luciferase assay
with the Dual Luciferase Assay kit on a Modulus microplate. MiR-155
and control plasmids were generous gifts from Dr. Yangchao Chen (Chinese University of Hong Kong). Luciferase constructs were generated
by Geneway Biotech Co. (Shanghai, China). Briefly, the entire 30 -UTR or
30 -UTR-MUT of Arrb2 and GSK-3b genes were cloned into pBluescript
SK vector and then cloned into psicheck2 vector.

Immunofluorescent staining
Cells or tissue slides were fixed with 3.7% formaldehyde in PBS for
20 min. at RT and stained with anti-cTnT antibody, then Alexa fluor 546conjugated secondary antibody (Molecular Probes, Eugene, OR, USA).
Cells or slides were examined by use of the Olympus IX70 microscope.

Myocardial infarction-reperfusion (I/R) injury and
cell delivery
Male mice were anesthetized with 5% isoflurance and maintained by
inhalation of 1.5% isoflurance driven by 100% oxygen flow and ventilated by use of a rodent ventilator. Myocardial infarction was induced as
described [16]. At 30 min. after left anterior descending ligation, 20 ll
basal IMEM medium without cells (control group) or with 2 9 105
Sca-1+ cells stained with PKH2 green fluorescent cell linker kit (cell
injection group) were injected into the infarction and border zones of
hearts by use of 29-gauge needles. After cell injection, hearts were reperfused for 1 hr, the chest was sutured with silk and all mice were allowed
to recover. At 14 days after surgery, cardiac function was analysed.
Every group has six mice and sham mice were as a control. At the end
of the experiment, mice were killed, and hearts were collected for
western blot analysis or were perfusion-fixed, embedded in paraffin, and
cut transversely into 6–8 lm thick sections at the level of the papillary
muscle. Sections were stained with anti-cTnT antibody and scanned.

Cardiac functional analysis
Cardiac function was detected by use of the SPR-839 instrument (Millar
Instruments, Houston, TX, USA) [16]. In anesthetized mice, systolic and
diastolic arterial blood pressure was recorded by means of a microtip
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pressure transducer inserted into the right carotid artery. The catheter
was then advanced into the left ventricle to measure cardiac functions
in the closed-chest preparation. Then cardiac tissues were harvested for
western blot and real-time PCR analyses.

Statistical analysis
Data are reported as mean  SEM and analysed by one-way ANOVA followed by a Holm-Sidak post hoc analysis. Differences were considered
statistically significant at P < 0.05.

Results
Arrb2 promoted 5aza-induced cardiac myocyte
differentiation in CSCs
The expression of cardiomyocye markers showed that 5aza induced
cardiac myocyte differentiation in Sca-1+ CSCs at 3 weeks (Fig. 1A).
So this time-point was used in our current study. Arrb2 was up-regulated at both mRNA and protein levels at 3 weeks after 5aza treatment
(Fig. 1B and C). Furthermore, Arrb2 overexpression could increase
the mRNA expression of MYH6 and cTnT on RT-PCR and the level of
cTnT on immunofluorescence assay (Fig. 1D and E), which suggested
that Arrb2 promoted 5aza-induced Sca-1+ cell differentiation to
cardiomyocytes.
To evaluate whether 5aza-induced Sca-1+ cell differentiation was
through Arrb2, we used Sca-1+ cells from Arrb2-KO mice. 5aza could
not up-regulate the expression of cardiac cell markers MYH6, GATA4
and cTnT in Sca-1+ cells from Arrb2-KO mice as compared with WT
mice (Fig. 1F), which suggests that 5aza induced Sca-1+ cell differentiation via an Arrb2–dependent manner. Thus, we further determined
the mechanisms responsible for Arrb2–dependent differentiation of
5aza-treated Sca-1+ cells.

MiR-155 inhibited 5aza-induced myocardiac
differentiation and was regulated by Arrb2
MiR-155 is a potential regulator for Arrb2 expression as suggested
by analysis with Targetscan. We found miR-155 level decreased in
CSCs after 3 weeks of 5aza treatment (Fig. 2A). To study the role
of miR-155, we generated a construct expressing miR-155. Overexpression of miR-155 rescued the increased expression of the
cardiac marker cTnT (Fig. 2B), so miR-155 inhibited the myocardiac differentiation.
To determine the relationship between miR-155 and Arrb2, we
detected the changes in miR-155 level in Arrb2–transfected Sca-1+
CSCs by RT-PCR. Arrb2-KO inhibited the level of miR-155 in WT
cells (Fig. 2C), which supports a relationship between Arrb2 and
miR-155.
The potential target site for miR-155 interaction is at nucleotides
145-151 of the mouse Arrb2 30 -UTR as suggested by analysis with
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Fig. 1 Effect of Arrb2 on 50 -azacytizine-induced differentiation of cardiac stem cells (CSCs) to cardiomyocytes. (A) Isolated Sca-1+ cells from wildtype (WT) mice were seeded 1 day before cells were treated with 50 -azacytizine (5aza) at 10 lM. After 3 days’ treatment, cell culture medium was
changed every 3 days for 2 and 3 weeks. Relative gene expression of cardiomyocyte markers including MYH6, GATA4, and cTnT were detected by
RT-PCR. (B and C) isolated Sca-1+ cells from wild-type (WT) mice were treated with 5aza at 10 lM for 3 weeks. Arrb2 expression was determined
by RT-PCR (B) and western blot analysis (C). (D and E) Sca-1+ cells from WT mice were transfected with full-length Arrb2 or control vector. After
24 hrs, cells were treated with 5aza as in A; the level of cTnT was detected by fluorescence assay (D) and the expression of MYH6, GATA4 and
cTnT by RT-PCR (E). (D) It shows phase-contrast (transmission) and fluorescence images. GFP shows transfected cells; scale bar = 15 lm. (F)
Sca-1+ cells from WT and Arrb2-knockout (KO) mice were treated with 5aza as in A. Real-time PCR analysis of the mRNA levels of MYH6, GATA4,
and cTnT. Data are mean  SEM of three experiments. *P < 0.05; **P < 0.01.
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A

B

C

Fig. 2 MiR-155 inhibits 5aza-induced differentiation of CSCs into cardiomyocytes through Arrb2. (A) RT-PCR analysis of the expression of miR-155
in Sca-1+ cells from WT mice treated as in Figure 1A. (B) Sca-1+ cells from WT mice were transfected with miR-155 plasmid or empty plasmid
control. After 24 hrs, cells were treated with 5aza and the expression of MYH6 and cTnT was examined by RT-PCR. (C) Sca-1+ cells from WT and
Arrb2-KO mice were treated with 5aza and miR-155 expression was examined as in A. Data are mean  SEM of three experiments. **P < 0.01.

Targetscan (Fig. 3A). To test whether miR-155 could directly target
the 30 -UTR of Arrb2 mRNA in a sequence-specific manner, we generated a luciferase construct harbouring a potential binding site for
miR-155 and produced a mutant construct with potential target sites
mutated (Fig. 3B). Luciferase activity decreased significantly in cells
transfected with luc-b–arrestin2 on cotransfection with miR-155, with
no significant difference in luciferase activity on cotransfection with
the mutated construct and miR-155 (Fig. 3C). So miR-155 might
target Arrb2 and inhibit its expression, but because Arrb2 will inhibit
the expression of miR-155. Thus, there is a loop pathway between
Arrb2 and miR-155 to maintain the function of Arrb2 promoting CSC
differentiation.

A

B

C

GSK3b is required for 5aza-mediated myocardiac
differentiation and targeted by miR-155
To clarify the downstream molecule of miR-155, we analysed the
function of GSK3b, another probable target of miR-155, determined
via Targetscan, in 5aza-induced differentiation. Computational analysis indicated that miR-155 potentially targets mouse GSK3b at nucleotides 4863-4869 and 265-271 (Fig. 4A). We generated luciferase
constructs harbouring two potential binding sites for miR-155 and
produced a mutant construct with potential target sites mutated
(Fig. 4B). Luciferase activity decreased significantly in luc-GSK3b–
transfected cells on cotransfection with miR-155, with no significant
difference on cotransfection with the mutated construct and miR-155
(Fig. 4C). So GSK3b is the target of miR-155.
To determine the function of GSK3b, we treated Sca-1+ cells with
its inhibitor, SB216763, at 10 lM, together with 5aza for the first
3 days. The effective concentration was as described previously and
in our preliminary experiment [17]. SB216763 could inhibit the 5azainduced expression of cardiac markers (Fig. 5A), which suggested
that the activity of GSK3b was required for 5aza-mediated myocardiocyte differentiation.
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Fig. 3 Arrb2 is a miR-155 target. (A) Sequence alignment of miR-155
and its target site in the 30 -UTR of Arrb2 (downloaded from http://www.
targetscan.org). (B) The seed region of Arrb2 30 -UTR was mutated as
indicated. (C) HEK293T cells were cotransfected with 60 ng miR-155
plasmid or empty EGFP plasmid control and 0.1 lg psicheck2 30 -UTRWT (WT Arrb2) or psicheck2 30 -UTR-MUT (mutant miR-155 target site
in Arrb2 30 -UTR). Cells were collected 48 hrs after transfection and
analysed by dual luciferase reporter assay. The psicheck2 vector that
provided the constitutive expression of Renilla luciferase was cotransfected as an internal control. Data are mean  SEM of four experiments. **P < 0.01.
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Fig. 4 MiR-155 targets GSK3b. (A) Two
possible GSK3b sites could be targeted by
miR-155 as in Figure 3A. (B) The seed
regions of GSK3b 30 -UTR were mutated
as indicated. (C) Luciferase assay of psicheck2 30 -UTR-WT (WT GSK3b) or psicheck2 30 -UTR-MUT (mutant miR-155
target site in GSK3b 30 -UTR) and others
measured as in Figure 3C. Data are
mean  SEM of four experiments.
**P < 0.01.

Fig. 5 GSK3b is involved in 5aza-induced
differentiation of CSCs to cardiomyocytes.
(A) Sca-1+ cells from WT mice were treated with 5aza as in Figure 1A and incubated with or without SB216763 at 10 lM
for the first 3 days. The mRNA expression
of MYH6 and cTnT was analysed by RTPCR analysis. (B) Sca-1+ cells from WT
and Arrb2-KO mice were treated with 5aza
as in Figure 1A. The expression of total
and phosphorylated Akt (p-Akt), total and
p-GSK3b were analysed by western blot.
(C) Quantification of p-Akt levels shown in
B. protein level were normalized to AKT.
(D) Quantification of p-GSK3b levels
shown in B. protein level were normalized
to GSK3b. Data are mean  SEM of four
experiments. *P < 0.05; **P < 0.01.

B

C

A

C

B

D

5aza promotes Sca-1+ cell transition to
cardiomyocytes through an Arrb2/miR-155/GSK3b
pathway
To analyse the signalling pathways involved in myocardiac differentiation, we examined the effect of Arrb2 on changes in GSK3b

expression. 5aza inhibited the phosphorylation of GSK3b. However,
Arrb2-KO in Sca-1+ cells promoted phosphorylation of GSK3b
and inhibited its activity (Fig. 5B and D). Thus, Arrb2 participated
in 5aza-induced CSC transition to cardiomyocytes by promoting
GSK3b activation.
Akt is a well-known upstream inhibitor of GSK3b activation. To
exclude the function of Akt on GSK3b activation, we detected changes
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plantation of Sca-1+ cells from WT mice could protect cardiac function, including ejection fraction, cardiac output, stroke volume and
Vmax (P < 0.01 versus WT mice injected with medium). However,
cardiac function measures did not differ with transplantation of Sca1+ cells from Arrb2-KO and from WT mice, except for impaired
indexes of arterial elastance and Tau-weiss (P < 0.01 versus WT
mice injected with medium; P < 0.01 versus WT mice injected with
WT Sca-1+ CSCs) (Table 1).
To exclude the affection of background expression of Arrb2 in WT
mice, we transplanted WT or Arrb2 KO Sca-1+ CSCs to Arrb2 KO
mice with myocardial infarction, high level of Arrb2 equal to better
performance of cardiac function, including ejection fraction, cardiac
output, stroke volume and Vmax (Table 2), which verified the important role of Arrb2 in heart repair.

A

B

Discussion
Fig. 6 Arrb2/miR-155/GSK3b pathway is important in CSC-mediated cardiac repair. Isolated 2 9 105 Sca-1+ cells from WT or Arrb2-KO mice
were injected immediately into infarcted and border zones of the mouse
heart after myocardial infarction (MI). Hearts were then reperfused for
1 hr. After 2 weeks, 2-mm sections of hearts near the mid-ventricles
were collected. (A) Fluoresence microscopy of hearts for WT mice with
MI injected with WT Sca-1+ cells and stained with cTnT. Red shows
cardiomyocytes; green shows injected Sca-1+ cells; blue shows DAPIstained cell nuclei; scale bar, 40 lm; n = 6. (B) Western blot analysis
of the expression of Arrb2, total Akt and p-Akt, and total and p-GSK3b.
GADPH was a loading control. The column shows the quantification of
the protein expression. Protein levels were normalized to GAPDH or
total protein; n = 3; *P < 0.05; **P < 0.01 versus WT.

in Akt activity. Phosphorylation of Akt was increased in 5aza-treated
CSCs, and Arrb2-KO in Sca-1+ cells inhibited 5aza-induced activation
of Akt. The mortality of the I/R model in mice is about 40%. Because
all the change rules are in contrast to the changes in AKT as the inhibitor to GSK3b (Fig. 5B and C), we concluded that Arrb2 promoted the
activation of GSK3b by inhibiting miR-155 but not Akt.

Arrb2/miR-155/GSK3b pathway in CSC-mediated
cardiac repair
To determine the role of the Arrb2/miR-155/GSK3b pathway in
CSC-mediated cardiac repair in vivo, we injected stem cells from WT
and KO mice into the hearts of mice with myocardial infarction. After
2 weeks, immunofluorescence assay revealed that the injected Sca-1+
cells could differentiate into myocardial cells (Fig. 6A). Arrb2 protein
was expressed in Arrb2-KO mice after transfer of Sca-1+ CSCs from WT
mice (Fig. 6B), which suggests that the transplanted cells could survive
in the mice with myocardial infarction. Furthermore, in KO mice, the low
protein level of Arrb2 caused low phosphorylation of Akt and high phosphorylation of GSK3b, which agrees with in vitro results (Fig. 6B).
Cardiac function analysis showed that myocardial infarction
(injected with medium) impaired cardiac function significantly as
compared with the sham control (P < 0.01 versus sham), and trans1568

Recently, both experimental and clinical findings have revealed that
the heart can replace cardiomyocytes throughout life, but this
response is inadequate to compensate for major injuries such as
myocardial infarction [18]. So resident CSCs could be stimulated to
differentiate into cardiomyocytes. Resident Sca-1+ CSCs, existing in
humans and mice [4, 19], have therapeutic functions on the heart
because of their differentiation potential. We used the 5aza-induced
differentiation model in vitro, and showed that Arrb2 could promote
the differentiation of Sca-1+ cells to cardiomyocytes, which suggested an important role of Arrb2 in Sca-1+ cell transition and promoted us to explore the mechanisms of Arrb2 mediated Sca-1+ CSCs
transition to cardiomyocyte. As 5-Azacytidine can induce gene
expression through demethylation [20], we deduced that 5-Azacytidine regulated b-arrestin2 expression by decreasing the degree of
methylation of the b-arrestin2 gene or other genes. In this study, we
focused on the pathway regulated by b-arrestin2, but how 5-Azacytidine regulated b-arrestin2 expression still needs further research.
MiR-155, a well-known multifunctional miRNA, was indicated to play
a crucial role in various physiological and pathological processes such
as haematopoietic lineage differentiation, immunity, inflammation,
cancer, and cardiovascular diseases [21], but its role in CSC differentiation is not clear. Our results showed that miR-155, the predicted regulator of Arrb2, inhibited the 5aza-induced differentiation of Sca-1+ cells
to cardiomyocytes and was regulated by Arrb2. So miR-155 might
locate downstream of Arrb2. However, dual luciferase reporter assay
showed that miR-155 also inhibited the expression of Arrb2. We suggest a loop pathway between miR-155 and Arrb2, which explains the
mechanism for its participation in regulating cardiovascular diseases.
As the downstream of Arrb2 and the target of miR-155, GSK3b
promoted the 5aza-induced murine Sca-1+ cell differentiation. This
result is the same as its role in cardiomyocyte differentiation of murine bone marrow-derived mesenchymal stem cells [22]. Although
GSK3b is regulate by Arrb2 in cell apoptosis and target by miR-155 in
T-cell proliferation has been reported [5, 23], we analysed the relationship among the three factors, and explored the important roles of
Arrb2/miR-155/GSK3b pathway in cardiomyocyte differentiation of
Sca-1+ cell. Furthermore, we verified that AKT and GSK3b are down-
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Table 1 Effects of Sca-1+ CSCs on the cardiac function of wild-type mice with myocardial infarction
14 days after myocardial I/R injury
Sham

Vehicle

Wild-type sca-1 cells

Arrb2 KO sca-1 cells

HR (b.p.m)

477  23.3

468  23.6

419  5.6

505  23.9

%EF

69.6  1.5

45.6  1.5*

60.3  2.2*,†

57.3  1.2*,†

LVDP, mmHg

84.4  0.9

71.3  6.3*

62.0  2.2

70.7  5.3

8410  982.3

3491  448.1*

6123  662.6

6962  606.5†

3.9  0.3

9  1.1*

4.18  0.5†

6.4  0.4†,‡

Tau-weiss

12.2  0.9

8.5  1.1*

11.1  0.3†

7.5  1.3*,‡

EDV

25.2  0.9

18.2  1.3*

24.2  1.3†

22.5  0.7

Dp/dt max

7994  880

5595  1783

4165  75

9055  3066

Dp/dt min

6547  700

5394  2382

4383  393

9203  2129

Stroke volume

17.7  5.9

9  2.2

10.6  5.9

13.7  1.6

Vmax (ll)

26.3  4.0

20.6  3.7

24.6  2.7

23.9  1.9

CO (ll/min.)
E(a)

†

*P < 0.01 versus sham.
†P < 0.01 versus WT mice injected with medium.
‡P < 0.01 versus WT mice injected with WT type Sca-1+ cells.
Data are mean  SEM of six experiments.
HR: heart rate; EF: ejection fraction; LVDP = ESP-EDP; ESP: end-systolic pressure; EDP: end-diastolic pressure; CO: cardiac output; E(a): arterial
elastance.

Table 2 Effects of Sca-1+ CSCs on the cardiac function of Arrb2-KO mice with myocardial infarction
14 days after myocardial I/R injury
%EF

CO (ll/min.)

Stroke volume

Vmax (ll)

Wild-type sca-1 cells

67.4  2.3

11493  2600

21.16  1.56

31.35  1.3

Arrb2 KO sca-1 cells

48.95  1.6*

7174  755*

13.29  1.1*

27.25  3.1*

*P < 0.05 compared with wild-type sca-1 injection.
Data are mean  SEM of six experiments.
EF: ejection fraction; CO: cardiac output.

stream of b-arresin2. However, GSK3b activity was not affected by
Akt phosphorylation as usual. As the protected function of GSK3b to
regional myocardial ischaemia/reperfusion injury has been verified
[24, 25], so the Arrb2/miR-155/GSK3b pathway might be a new target for CSC-mediated cardiac repair.
We transplanted CSCs from WT or Arrb2 KO mice into mice with
myocardial infarction to analyse the function of Arrb2 in CSC-participating cardiac repair. In WT infarcted mice, Arrb2–KO CSCs showed
the same protective functions, except for arterial elastance perhaps
because the background of Arrb2 in WT infarcted mice affected its
actual role. Otherwise, it might be caused by the interference of the
adrenal-dependent neurohormonal mechanisms. b-arrestins (including Arrb1and Arrb2) have been shown to activate epidermal growth
factor receptor by eliciting a G-protein–independent signals in vitro,
so they might be beneficial for the failing heart. However, with regard

to the heart, Arrb1 preferred to perform a G-protein dependent function, and regulates the majority of cardiovascular G protein-coupled
receptors, especially adrenal and central sympathetic nervous system
a2ARs, to perform a negative impact on post-myocardial infarction
heart failure via cardiac and adrenal-dependent neurohormonal mechanisms [26]. Arrb2 has the same effect as Arrb1 on cardiac b1ARs
and Adrenal a2AR internalization [27]. So it is not strange that Arrb2
also protect the heart from damage. As Arrb20 s role was affected by
adrenal-dependent neurohormonal mechanisms, only development of
tissue-specific KO mice can provide definitive answers to this important question. However, low Arrb2 level agreed with decreased phosphorylation of AKT and increased phophorylation of GSK3b, findings
also found in vitro. Furthermore, we transplanted WT or Arrb2 KO
Sca-1+ CSCs to Arrb2 KO mice with myocardial infarction, high level
of Arrb2 equal to better performance of cardiac function, verified the
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vital function of Arrb2 in cardiac repair. The Arrb2/miR-155/GSK3b
pathway may be a new mechanism with implications for treatment of
heart disease.
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